ENTREPRENEURSHIP: Israel Meir Kirzner’s Theory

By Dr. David Edward Marcinko; MBA MEd

SPONSOR: http://www.CertifiedMedicalPlanner.org

***

***

Kirzner’s theory places the entrepreneur at the center of market coordination, arguing that markets function not because individuals possess perfect information, but because some individuals are alert to opportunities that others overlook. His work reframes the market as a dynamic, discovery‑driven process rather than a static system tending automatically toward equilibrium. In doing so, Kirzner offers a distinctive account of how coordination emerges in real-world economies marked by uncertainty, dispersed knowledge, and continual change.

At the heart of Kirzner’s framework is the concept of entrepreneurial alertness. Unlike definitions that portray entrepreneurs as innovators, risk‑bearers, or managers, Kirzner emphasizes the entrepreneur’s unique ability to notice previously unseen possibilities. This alertness is not a matter of deliberate search or specialized expertise; it is a readiness to perceive discrepancies in the market—unmet consumer demands, mispriced goods, or underutilized resources. When an entrepreneur recognizes such a discrepancy, they act to exploit it, and in doing so, they help correct the underlying error. This corrective action is what moves markets toward greater coordination.

Kirzner’s understanding of markets is inseparable from his view of knowledge. He argues that economic actors operate with incomplete and unevenly distributed information. No one possesses a full picture of the market, and errors are therefore inevitable. Yet these errors are not signs of market failure. Instead, they create the very conditions that make entrepreneurial discovery possible. The entrepreneur’s alertness allows them to detect what others have missed, and their actions reveal new information to the rest of the market. In this way, discovery is a social process: one person’s insight becomes a signal that guides the decisions of others.

This process is most clearly expressed through profit and loss, which Kirzner interprets as feedback mechanisms. Profit is the reward for having perceived an opportunity that others overlooked. It indicates that the entrepreneur has moved the market closer to a more coordinated state. Loss, by contrast, signals that the entrepreneur’s judgment was mistaken or that conditions have shifted. These signals are essential because they guide behavior without requiring any central authority. They allow countless individuals to adjust their plans in response to new information, creating a spontaneous order that no planner could design.

Kirzner’s theory also offers a distinctive view of competition. Rather than treating competition as a static state characterized by many firms producing identical goods, he describes it as a dynamic process of discovery. Entrepreneurs compete by being more alert than others—by noticing opportunities sooner or interpreting signals more effectively. This competitive process continually reshapes the market, pushing it toward greater coordination even as new opportunities and errors emerge. Competition, in Kirzner’s sense, is not a condition but an activity.

***

***

A key implication of this view is that markets are inherently open-ended. Because knowledge is never complete and conditions are always changing, the discovery process has no final equilibrium. Even if markets move toward coordination, new opportunities constantly arise. This makes the entrepreneur indispensable: without entrepreneurial alertness, markets would stagnate, and errors would persist uncorrected. The entrepreneur is the agent through whom markets learn.

Kirzner’s theory stands in contrast to other influential accounts of entrepreneurship. For example, while Schumpeter emphasizes innovation and “creative destruction,” Kirzner focuses on discovery and error correction. Schumpeter’s entrepreneur disrupts the market by introducing something fundamentally new; Kirzner’s entrepreneur restores coordination by recognizing what already exists but has not been noticed. These two views highlight different aspects of economic change, but Kirzner’s approach is more closely tied to the everyday functioning of markets and the continual adjustments that keep them coherent.

Kirzner’s insights also have implications for policy. Because entrepreneurial discovery depends on freedom of entry, flexible prices, and open competition, regulations that restrict these conditions can unintentionally suppress the discovery process. Barriers to entry reduce the number of individuals scanning the environment for overlooked opportunities. Price controls distort the signals that guide entrepreneurial judgment. Excessive regulation can therefore freeze the market in a state of uncorrected error. Kirzner does not argue that all regulation is harmful, but he warns that policymakers often underestimate the subtle, decentralized nature of discovery.

Ultimately, Kirzner’s theory presents a vision of markets as learning systems. Entrepreneurs are not heroic figures but ordinary individuals who happen to notice what others have missed. Their discoveries, guided by profit and loss, help coordinate the plans of millions of people who will never meet. Markets, in this view, are not perfect, but they are adaptive. They evolve through the continual interplay of error and discovery, ignorance and alertness. Kirzner’s contribution lies in showing that the true strength of markets is not their tendency toward equilibrium, but their capacity for self‑correction through entrepreneurial action.

COMMENTS APPRECIATED

EDUCATION: Books

SPEAKING: Dr. Marcinko will be speaking and lecturing, signing and opining, teaching and preaching, storming and performing at many locations throughout the USA this year! His tour of witty and serious pontifications may be scheduled on a planned or ad-hoc basis; for public or private meetings and gatherings; formally, informally, or over lunch or dinner. All medical societies, financial advisory firms or Broker-Dealers are encouraged to submit an RFP for speaking engagements: CONTACT: Ann Miller RN MHA at MarcinkoAdvisors@outlook.com -OR- http://www.MarcinkoAssociates.com

Like, Refer and Subscribe

***

EBOLA Virus

By Dr. David Edward Marcinko; MBA MEd

***

***

The Ebola virus is one of the most feared pathogens known to modern medicine, recognized for its rapid spread, severe symptoms, and high fatality rates. First identified in 1976 during simultaneous outbreaks in what are now the Democratic Republic of the Congo and South Sudan, the virus has since reappeared in periodic epidemics across sub‑Saharan Africa. Its name comes from the Ebola River near one of the earliest outbreak sites, and over time it has become synonymous with viral hemorrhagic fever and global public health emergencies.

Ebola belongs to the Filoviridae family and the Orthoebolavirus genus. Several species exist, but four are known to cause disease in humans: Zaire ebolavirus, Sudan virus, Bundibugyo virus, and Taï Forest virus. Among these, the Zaire species is the most lethal and has been responsible for the largest and deadliest outbreaks, including the 2013–2016 West African epidemic that infected tens of thousands of people. Although the average fatality rate across outbreaks is around half of those infected, some epidemics have recorded mortality as high as 90 percent.

Scientists believe that fruit bats serve as the natural reservoir for Ebola. The virus can spill over into human populations when people come into contact with infected animals such as bats, chimpanzees, gorillas, or forest antelopes. Once a human becomes infected, the virus spreads primarily through direct contact with bodily fluids of a sick or deceased person. These fluids include blood, vomit, feces, urine, saliva, sweat, breast milk, and semen. Contaminated objects, such as needles or bedding, can also transmit the virus. Importantly, Ebola does not spread through the air like influenza; a person must have direct exposure to infectious fluids. Individuals are not contagious until they begin showing symptoms, which helps guide containment strategies.

The incubation period for Ebola ranges from two to twenty‑one days. Early symptoms often resemble common illnesses, beginning with fever, fatigue, muscle pain, headache, and sore throat. As the disease progresses, more severe symptoms emerge, including vomiting, diarrhea, abdominal pain, and rash. In many cases, the virus causes internal and external bleeding, though bleeding is not as universal as popular portrayals suggest. Patients may bleed from the gums, nose, or puncture sites, and blood may appear in vomit or stool. As the infection worsens, organ failure, shock, and neurological complications such as confusion or irritability can occur. Without timely medical care, these complications often lead to death within days.

Diagnosing Ebola can be challenging because early symptoms mimic other tropical diseases such as malaria, typhoid fever, or meningitis. Laboratory confirmation typically requires specialized tests that detect viral RNA or antibodies. Because Ebola samples pose extreme biohazard risks, testing must be conducted in high‑containment laboratories. Rapid diagnosis is essential not only for patient care but also for preventing further spread.

***

***

Treatment for Ebola has improved significantly over the past decade. Historically, supportive care—such as rehydration, electrolyte replacement, oxygen therapy, and treatment of secondary infections—was the only option. Today, specific antiviral therapies exist for infections caused by the Zaire species. These include monoclonal antibody treatments that help the immune system neutralize the virus. Even with these advances, early intervention remains critical; patients who receive care soon after symptoms begin have a much higher chance of survival.

Vaccination has also transformed Ebola prevention. A licensed vaccine is available for the Zaire species and has been used effectively in outbreak settings to protect frontline workers and close contacts of infected individuals. However, vaccines for other Ebola species are still under development. Because outbreaks often occur in remote regions with limited healthcare infrastructure, vaccination campaigns must be paired with strong community engagement, safe burial practices, contact tracing, and infection‑control measures in healthcare facilities.

Ebola’s impact extends beyond the immediate health crisis. Survivors may experience long‑term complications, including vision problems, joint pain, fatigue, and neurological issues. The virus can persist in immune‑privileged sites such as the eyes, brain, and reproductive organs for months after recovery, which means survivors may require ongoing monitoring. Social stigma can also affect survivors and their families, making community reintegration an important part of recovery efforts.

COMMENTS APPRECIATED

EDUCATION: Books

SPEAKING: Dr. Marcinko will be speaking and lecturing, signing and opining, teaching and preaching, storming and performing at many locations throughout the USA this year! His tour of witty and serious pontifications may be scheduled on a planned or ad-hoc basis; for public or private meetings and gatherings; formally, informally, or over lunch or dinner. All medical societies, financial advisory firms or Broker-Dealers are encouraged to submit an RFP for speaking engagements: CONTACT: Ann Miller RN MHA at MarcinkoAdvisors@outlook.com -OR- http://www.MarcinkoAssociates.com

Like, Refer and Subscribe

***